ArticleCureus2025

Comparative Effectiveness of Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in Reducing Adverse Cardiovascular Events in Type 2 Diabetes.

Syed Zakir Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.